Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell Profiles

Author:

Xu Yitian12ORCID,Zhang Licheng12ORCID,Thaiparambil Jose1,Mai Sunny1,Perera Dimuthu Nuwan3ORCID,Zhang Jilu12,Pan Ping-Ying1ORCID,Coarfa Cristian3ORCID,Ramos Kenneth14,Chen Shu-Hsia12ORCID,El-Zein Randa1ORCID

Affiliation:

1. 1Houston Methodist Research Institute, Houston, Texas.

2. 2Immune Monitoring core, Houston Methodist Research Institute, Houston, Texas.

3. 3Dan L Duncan Comprehensive Cancer Center, Center for Precision Environmental Health, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.

4. 4Institute of Biosciences and Technology, Texas A&M University, Houston, Texas.

Abstract

Tumors accumulated with infiltrated immune cells (hot tumors) have a higher response rate to immune checkpoint blockade, when compared with those with minimal T-cell infiltration (cold tumors). We report here that patients with lung cancer with different racial backgrounds harbored distinct immune cell profiles in the tumor microenvironment. Compared with African Americans (AA), Caucasian Americans (CA) exhibited increased immune cell infiltration and vasculature, and increased survival. Changes of survival and immune profile were most pronounced among active smokers and nonsmokers, compared with former smokers and total patients. Neighborhood analysis showed that immune cells accumulated around cancer cells in CAs but not AAs. Our findings reveal intrinsic biological differences between AA and CA patients with lung cancer, suggesting that treatment plans should be tailored for patients with different racial backgrounds. Significance: We report biological racial differences among patients with lung cancer where Caucasians present a hot tumor microenvironment compared with cold tumor in AAs. Treatment plans should be customized to maximize therapeutic outcomes.

Publisher

American Association for Cancer Research (AACR)

Reference41 articles.

1. LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII;Stutz;Oncogene,2008

2. Mechanisms of receptor tyrosine kinase activation in cancer;Du;Mol Cancer,2018

3. Annual Report to the Nation on the Status of Cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state;Kohler;J Natl Cancer Inst,2015

4. Genetic evidence linking lung cancer and COPD: a new perspective;Young;Appl Clin Genet,2011

5. Breast cancer statistics, 2017, racial disparity in mortality by state;Desantis;CA Cancer J Clin,2017

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3